The Transitioning Children to Optimal Regimens of Paediatric Dolutegravir (TORPEDO) Study
The Transitioning children to Optimal Regimens of Paediatric Dolutegravir (TORPEDO) Study was conducted in Benin, Nigeria, and Uganda....
top of page
A framework to support new product introduction in national health systems
Resource Library
- Jun 23, 2022
EGPAF Guidance and Algorithm for Follow-Up of Children After Starting or Transitioning to pDTG
The purpose of this guidance from EGPAF is to aid health care workers and support caregivers and children initiated on, or switched to,...
100
- May 24, 2022
GAP-f pDTG Implementation Considerations for National Programmes
In mid-2021, national HIV programmes began to transition treatment for children living with HIV to dolutegravir (DTG) 10 ...
337
- Mar 17, 2022
Adult DRV/r (400/50mg) Clinical Action Memo
Darunavir (DRV) is a best-in-class protease inhibitor (PI) used in combination with other antiretroviral (ARV) drugs for the...
179
- Mar 17, 2022
CHAI DRV/r 2L Product Profile
A presentation with the latest information on DRV/r (400/50mg) and considerations for adult second line treatment optimization.
137
- Feb 10, 2022
EGPAF Guidance for Pediatric ARV Quantification and Supply Planning
This guidance from EGPAF is intended for national program managers; technical and clinical advisors; procurement entities; funding...
61
- Oct 18, 2021
Pediatric DTG Healthcare Worker Resources
CHAI has developed new resources to support healthcare worker decision-making and counselling around pDTG. pDTG HCW Worker Overview Video...
164
- Aug 16, 2021
Pediatric DTG Introduction: Transition Plan Templates
Fillable report and presentation template for governments to adjust as needed for introduction of pediatric DTG. English | French
58
- Jul 9, 2021
Community Resources for Pediatric DTG Scale-Up
Optimal and FASTER CAB members, with technical support from CHAI, developed a multi-media package of treatment literacy and advocacy...
42
- Apr 26, 2021
2021 WHO Optimal Formulary and Limited-Use List for ARVs for Children
This sixth edition of the Optimal Formulary and Limited-use List supports the transition to optimal WHO-recommended ART regimens for...
5
- Mar 15, 2021
Pediatric DTG Clinical Studies Repository
A CHAI-curated repository of clinical studies in the development and implementation of pediatric DTG.
10
- May 28, 2020
Optimizing 2L HIV Treatment with DTG-based Regimens
This memo highlights the patient benefits, cost savings and improved supply security associated with proactively switching eligible 2L...
12
- Aug 1, 2018
TLD Resources
CHAI's TLD resources help countries in creating the best plan for TLD introduction. CHAI TLD Clinical Action Memo CHAI DTG Use In Women...
52
bottom of page